O relatório
Notícias verificadas sobre financiamento, sedes e liderança das empresas mais inovadoras do mundo
105 relatórios e mais
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Ottimo Pharma Raises $140M in Series A
Ottimo Pharma, a Biotech company based in San Francisco, CA, has raised $140M in Series A at a $600M valuation led by OrbiMed, Avoro Capital.
Circle Pharma Raises $90M in Series D
Circle Pharma, a HealthTech company based in South San Francisco, CA, has raised $90M in Series D led by The Column Group.
Circle Pharma raises $90M Series D
Circle Pharma raises $90M in Series D. Biotech developing cell-permeable macrocycles for treating previously undruggable targets...
Ottimo Pharma raises $140M Series A at $600M valuation
Ottimo Pharma raises $140M in Series A at $600M valuation. Developing biosimilar cancer treatment to compete with Keytruda...
Albireo Pharma Headquarters - Office Location & Address
Discover Albireo Pharma's headquarters at 50 Milk St, Boston, MA 02109. Rare disease therapeutics developer. Learn about the office facilities and work environment.
Astellas Pharma Headquarters - Office Location & Address
Discover Astellas Pharma's headquarters at 2-5-1 Nihonbashi-Honcho, Tokyo 103-8411. Pharmaceutical company. Learn about the office facilities and work environment.
Ascendis Pharma Headquarters - Office Location & Address
Discover Ascendis Pharma's headquarters at 185 Alewife Brook Pkwy, Palo Alto, CA 02138. Biopharmaceutical company. Learn about the office facilities and work environment.
Bain Capital Specialty Finance Headquarters - Office Location & Address
Discover Bain Capital Specialty Finance's headquarters at 200 Clarendon St, Boston, MA 02116. Business development company. Learn about the office facilities and work environment.
Mostrando 9 relatórios • Página 1 • Categoria: all
Fique à frente do mercado
Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.